Paris, France

Michele Souyri


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Michele Souyri: Innovator in Molecular Detection

Introduction

Michele Souyri is a notable inventor based in Paris, France. He has made significant contributions to the field of molecular detection, particularly in the area of growth factor receptors. With a total of 2 patents, his work has implications for both research and clinical applications.

Latest Patents

Michele Souyri's latest patents include innovative methods for the detection of molecules with affinity for MPL polypeptides. One of his patents describes a polypeptide of a growth factor receptor family that encourages and/or is involved in the proliferation and/or differentiation of hematopoietic cell lines when obtained from the MPLV retrovirus. This polypeptide is capable of acting as a hematopoietic growth factor receptor and is recognized by antibodies directed against it. Additionally, he has developed nucleic acids encoding polypeptides of a growth factor receptor family, which have applications in diagnosing the expression of said ligand polypeptide.

Career Highlights

Michele Souyri is affiliated with the Institut National de la Santé et de la Recherche Médicale, where he conducts his research. His work has been instrumental in advancing the understanding of molecular interactions and their applications in medicine.

Collaborations

Michele has collaborated with notable colleagues, including Martine Charon and Sylvie Gisselbrecht, who have contributed to his research endeavors.

Conclusion

Michele Souyri's innovative work in molecular detection and growth factor receptors highlights his importance in the field of biomedical research. His patents reflect a commitment to advancing scientific knowledge and improving diagnostic methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…